Longitudinal Analysis of Anti-cardiolipin and Anti-beta 2-glycoprotein-I Antibodies in Recent-Onset Systemic Lupus Erythematosus : A Prospective Study in Swedish Patients
| Autor: | Christopher Sjöwall, Martina Frodlund, Charlotte Dahle, Tomas Walhelm |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
antiphospholipid antibody syndrome
anti-phospholipid antibodies Miscarriage anti-cardiolipin antibodies cardiovascular events Pharmacotherapy immune system diseases medicine pregnancy morbidities Myocardial infarction Seroconversion Prospective cohort study anti-β2-glycoprotein-I antibodies Original Research Rheumatology and Autoimmunity lcsh:R5-920 Reumatologi och inflammation biology business.industry anti-β 2-glycoprotein-I antibodies longitudinal analysis systemic lupus erthematosus General Medicine medicine.disease Isotype Immunology biology.protein Medicine Anti-cardiolipin antibodies Antibody business lcsh:Medicine (General) |
| Zdroj: | Frontiers in Medicine, Vol 8 (2021) Frontiers in Medicine |
| Popis: | Background: Anti-phospholipid syndrome (APS) and systemic lupus erythematous (SLE) are autoimmune disorders that often co-occur. Anti-phospholipid antibodies (aPL) are typical of both conditions and may be associated with vascular events and pregnancy-related morbidities. Whereas, aPL-screening is mandatory for individuals with suspected SLE, the clinical value of longitudinal aPL analyses in established SLE is unclear. Methods: We investigated the occurrence and variation of IgG/IgA/IgM anti-cardiolipin (aCL) and anti-beta 2-glycoprotein-I (anti-beta 2GPI) antibodies, using both the manufacturers cut-off and a cut-off based on the 99th percentile of 400 apparently healthy donors, in recent-onset SLE. Furthermore, we evaluated the relationships between aPL levels and SLE/APS manifestations, as well as the pharmacotherapy. Patients with SLE who met validated classification criteria were included in this prospective study (N = 54). Samples were obtained at 0, 6, 12, 24, 36, 48, 60, 72, 84, and 96 months after SLE diagnosis. Results: Depending on the cut-off applied, 61.1 or 44.4% showed a positive result for at least one aPL isotype or the lupus anticoagulant test over time. Median values for all six aPL isotypes numerically decreased from inclusion to last follow-up, but none of the isotypes met statistical significance. Seroconversion (from positive to negative, or the opposite direction) was occasionally seen for both aCL and anti-beta 2GPI. IgA and IgM anti-beta 2GPI were the most common isotypes, followed by IgM aCL. Presence of IgG aCL associated significantly with myocardial infarction and miscarriage, and IgG/IgA anti-beta 2GPI with miscarriage. Conclusion: aPL were common during the first years of SLE. Even though the levels fluctuated over time, the patients tended to remain aPL positive or negative. Repeated aPL testing in the absence of new symptoms seems to be of uncertain value in patients with recent-onset SLE. Funding Agencies|Swedish Rheumatism Association; Region Ostergotland (ALF Grants); King Gustaf Vs 80-year Anniversary Foundation; King Gustaf V and Queen Victorias Freemasons Foundation |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|